A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients with Stage 0-III Colon Cancer, Phase III
For more information about this clinical trial, click here.
Schema & Eligibility SWOG S0820
CoxHealth Medical Center, Springfield, MO
Mercy Hospital, Springfield, MO
Freeman Health System, Joplin, MO
Good Samaritan Regional Health Center, Mt. Vernon, IL